<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>28</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Diabetes-Associated Dry Eye Syndrome: Clinical Features, Underlying Molecular Mechanisms and Treatment Options</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>6</LastPage>
			<ELocationID EIdType="pii">212234</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2024.212234</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Department of Ophthalmology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5715-7322</Identifier>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Department of Ophthalmology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3221-8648</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>The global diabetes epidemic continues to rise, with complications extending beyond diabetic retinopathy (DR) and cataracts to include dry eye syndrome (DES), or keratoconjunctivitis sicca. Approximately 54% of individuals with diabetes experience DES, yet the condition remains poorly understood. Diabetes mellitus (DM) disrupts tear film homeostasis through mechanisms such as lacrimal gland dysfunction, Meibomian gland dysfunction, and abnormal tear dynamics. Chronic hyperglycemia, diabetic neuropathy, systemic inflammation, and altered mucin secretion exacerbate these changes, leading to tear instability and ocular surface damage. Risk factors for DES include advanced age, female sex, smoking, and higher glycated hemoglobin (HbA1c) levels. Surgical interventions for diabetes-related ocular complications, such as cataract surgery, intravitreal injections, and pan-retinal photocoagulation, further increase the risk of DES. Treatment strategies for diabetic dry eye (DMDES) include artificial tears, anti-inflammatory drugs like corticosteroids, cyclosporin A, tacrolimus, and autologous blood serum. However, these treatments address symptoms rather than underlying causes, with potential side effects. Emerging therapies, including gene-based approaches, show promise but require further research. Given the high prevalence of DMDES and its potential impact on quality of life, routine ocular surface and tear function assessments are recommended in diabetic care. Early diagnosis, glycemic control, and personalized treatment regimens are critical for preventing complications. Future studies must focus on targeted therapies to better manage DMDES and improve patient outcomes.&lt;br /&gt; </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Diabetes Mellitus</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Dry eye syndrome</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Diabetic Neuropathy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Tear Film Instability</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lacrimal Gland Dysfunction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meibomian Gland Dysfunction</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hyperglycemia</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Ocular Inflammation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_212234_8289b517eec6d7a7f6a6e9c2a5191e2f.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>28</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Role of Varicocelectomy in Enhancing Fertility Outcomes: A Review Article</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>6</LastPage>
			<ELocationID EIdType="pii">212236</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2024.212236</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Deylami</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3221-8648</Identifier>

</Author>
<Author>
					<FirstName>Mehdi Younesi</FirstName>
					<LastName>Rostami</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Behkam</FirstName>
					<LastName>Rezaiemehr</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5715-7322</Identifier>

</Author>
<Author>
					<FirstName>Mohadeseh</FirstName>
					<LastName>Modanlu</LastName>
<Affiliation>Department of Medical Sciences, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0009-0000-7921-1414</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Shahbazinia</LastName>
<Affiliation>Department of Pharmacy, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0008-5021-5989</Identifier>

</Author>
<Author>
					<FirstName>AmirReza</FirstName>
					<LastName>Ranjbar</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0009-0000-1431-894X</Identifier>

</Author>
<Author>
					<FirstName>Fatemeh</FirstName>
					<LastName>Rajabian</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0009-0003-1020-4891</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Varicocele is the leading cause of male infertility and can often be corrected or improved through a range of surgical and radiological methods. Consequently, it appears logical that varicocele should be treated in infertile men who have this condition. Varicocele, an enlargement of the pampiniform plexus veins affecting 15–20% of men, is more common in those with infertility concerns. Its impact on spermatogenesis is linked to oxidative stress, hypoxia, and immune responses, which may be alleviated by varicocelectomy. Varicocelectomy has been associated with improvements in sexual function, hormonal profiles, and fertility, particularly in men with hypogonadism. This review evaluates its effects on testosterone levels, semen quality, and fertility outcomes, highlighting the advantages of microsurgical varicocelectomy, such as improved sperm quality, higher spontaneous pregnancy rates, and fewer complications. However, patient outcomes depend on surgical indications, pre-existing conditions, and individual expectations.  Emerging evidence suggests that repairing varicoceles before assisted reproductive technology (ART) can enhance fertility outcomes. Further studies are needed to refine treatment criteria and expand options for diverse patient groups, including adolescents and men with pain-related varicoceles. The review also emphasizes the need for standardized diagnostic and treatment protocols.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Varicocele</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Male infertility</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Varicocelectomy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">oxidative stress</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">spermatogenesis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Testosterone Levels</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Semen quality</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Assisted Reproductive Technology</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_212236_6094dd94609efb273c4f36e2051b3684.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>28</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Pain Management and Anesthesia Considerations in Thyroid Carcinoma: An Emphasis on Anaplastic, Papillary, Follicular, Hurthle Cell, and Medullary Subtypes</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>7</LastPage>
			<ELocationID EIdType="pii">212239</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2024.212239</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Amin</FirstName>
					<LastName>Ghanbarpour Juybari</LastName>
<Affiliation>Department of Anesthesiology, Mazandaran University of Medical Science, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5715-7322</Identifier>

</Author>
<Author>
					<FirstName>Alireza Karimi</FirstName>
					<LastName>Varaki</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari,Mazandaran, Iran,</Affiliation>
<Identifier Source="ORCID">0009-0005-0353-5179</Identifier>

</Author>
<Author>
					<FirstName>Ali</FirstName>
					<LastName>Pahnabi</LastName>
<Affiliation>Mazandaran University of Medical Sciences, Sari, Iran,</Affiliation>
<Identifier Source="ORCID">0000-0002-4136-0550</Identifier>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3221-8648</Identifier>

</Author>
<Author>
					<FirstName>Mohamad Javad</FirstName>
					<LastName>Bay</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari,Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0002-4623-6249</Identifier>

</Author>
<Author>
					<FirstName>Mohammad</FirstName>
					<LastName>Modarresi</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari,Mazandaran, Iran,</Affiliation>
<Identifier Source="ORCID">0009-0003-1632-5707</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Thyroid carcinoma encompasses a heterogeneous group of malignancies, each with distinct biological behaviors, therapeutic strategies, and challenges in pain management and anesthesia. This review delves into the subtypes of thyroid carcinoma—anaplastic, papillary, follicular, Hurthle cell, and medullary—emphasizing the critical interplay between effective pain control and surgical outcomes. Anaplastic thyroid carcinoma (ATC), characterized by rapid progression and local invasion, necessitates multimodal pain management, including systemic analgesics and nerve blocks, to address severe discomfort caused by structural compression. Papillary and follicular thyroid carcinomas, generally indolent but prone to recurrence, require tailored anesthesia and postoperative pain protocols, incorporating techniques like cervical plexus blocks to reduce opioid reliance. Unique challenges are posed by Hurthle cell carcinoma (HCC) and medullary thyroid carcinoma (MTC). HCC, often associated with poor prognosis, demands precise surgical techniques to enhance survival, while MTC involves hereditary and sporadic forms with systemic manifestations complicating pain management. Advanced surgical methods, including transoral and robotic thyroidectomy, are explored for their efficacy in reducing complications and enhancing patient satisfaction. For patients with genetic predispositions, early prophylactic surgeries significantly mitigate risks. Anesthesia considerations are paramount, particularly in advanced ATC, where airway management is crucial. Techniques such as total intravenous anesthesia (TIVA) and regional nerve blocks optimize perioperative outcomes while minimizing systemic side effects. This narrative underscores the importance of interdisciplinary collaboration and individualized care in addressing the multifaceted needs of thyroid carcinoma patients, ultimately aiming to improve survival rates and quality of life.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">thyroid carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">papillary carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Follicular Carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">medullary carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anaplastic Carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pain management</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Surgical Techniques</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">lymph node dissection</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">genetic testing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognosis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_212239_b059d1433708f66fab8f80404deedf66.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>01</Month>
					<Day>09</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Unraveling the Spectrum of Thyroid Carcinoma: From Aggressive Anaplastic to Curable Differentiated Forms - A Comprehensive Narrative Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>9</LastPage>
			<ELocationID EIdType="pii">213077</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.213077</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Rostam</FirstName>
					<LastName>Poormousa</LastName>
<Affiliation>Department of Otolaryngology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-7298-7789</Identifier>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-3221-8648</Identifier>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-5715-7322</Identifier>

</Author>
<Author>
					<FirstName>Mohamad Javad</FirstName>
					<LastName>Bay</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari,Mazandaran, Iran</Affiliation>
<Identifier Source="ORCID">0009-0002-4623-6249</Identifier>

</Author>
<Author>
					<FirstName>Kasra</FirstName>
					<LastName>Hasannejad</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari,Mazandaran, Iran,</Affiliation>
<Identifier Source="ORCID">0000-0002-6168-662X</Identifier>

</Author>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Talaei</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Iran,</Affiliation>
<Identifier Source="ORCID">0009-0009-6640-0385</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>12</Month>
					<Day>14</Day>
				</PubDate>
			</History>
		<Abstract>Thyroid carcinoma encompasses a spectrum of malignancies with distinct clinical characteristics, management strategies, and prognoses. This narrative review article provides an in-depth examination of anaplastic thyroid carcinoma (ATC), papillary thyroid carcinoma (PTC), Hurthle cell carcinoma (HCC), and medullary thyroid carcinoma (MTC), offering insights into their epidemiology, diagnostic and treatment modalities. Anaplastic thyroid carcinoma is a highly aggressive and undifferentiated form of thyroid cancer, often associated with poor prognosis. Treatment strategies include combined resection and radiotherapy, but late-stage cases exhibit limited therapeutic options, emphasizing the need for novel therapeutic approaches. Papillary thyroid carcinoma, the most common thyroid cancer, generally carries a favorable prognosis. The article discusses surgical interventions like total thyroidectomy and lobectomy, along with minimally invasive techniques such as transoral endoscopic thyroidectomy vestibular approach (TOETVA) and robotic thyroidectomy. The importance of considering health-related quality of life in the treatment decision-making process is highlighted. Hurthle cell carcinoma, a rare and aggressive subtype, is explored with a focus on factors influencing prognosis. Surgical management, including thyroid lobectomy, completion thyroidectomy, and iodine-131 therapy, is discussed in detail. Medullary thyroid carcinoma is categorized into hereditary and sporadic forms, each requiring specific approaches. The review emphasizes the significance of genetic testing for patients at risk of multiple endocrine neoplasia syndrome (MEN2) and the need for early thyroidectomy in genetic RET mutation carriers. Furthermore, the article evaluates the extent of surgery, the role of radioiodine therapy, and the significance of follow-up in treating differentiated thyroid carcinomas (DTC). Surgical approaches for follicular thyroid carcinoma (FTC) and factors influencing the decision for total thyroidectomy versus lobectomy are elaborated upon. In summary, this narrative review provides a comprehensive overview of thyroid carcinoma subtypes, their epidemiology, surgical interventions, and postoperative management, offering valuable insights for clinicians and researchers in the field.&lt;br /&gt; </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">thyroid carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anaplastic Thyroid Carcinoma (ATC)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Papillary Thyroid Carcinoma (PTC)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Hurthle Cell Carcinoma (HCC)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Medullary Thyroid Carcinoma (MTC)</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Epidemiology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Treatment strategies</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">genetic testing</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">RET Mutation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">thyroidectomy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_213077_0713392a9199de35326f8cd95b68d47c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Predictive Modeling of Linezolid-Associated Hyponatremia in Critical Care: A Biomarker-Augmented Risk Framework</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>9</LastPage>
			<ELocationID EIdType="pii">229209</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.229209</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Saaedeh</FirstName>
					<LastName>Chalaki</LastName>
<Affiliation>Specialist in Emergency Medicine</Affiliation>

</Author>
<Author>
					<FirstName>Vahideh</FirstName>
					<LastName>Chalaki</LastName>
<Affiliation>PharmD, Specialist in Pharmacoeconomics</Affiliation>

</Author>
<Author>
					<FirstName>Seyyed Ghodsiyeh</FirstName>
					<LastName>Esmaeilnejad</LastName>
<Affiliation>Specialist in Emergency Medicine</Affiliation>

</Author>
<Author>
					<FirstName>Seyyed Mohammad</FirstName>
					<LastName>Hosseinnejad</LastName>
<Affiliation>Specialist in Emergency Medicine</Affiliation>

</Author>
<Author>
					<FirstName>Mona</FirstName>
					<LastName>Foghani Ahangari</LastName>
<Affiliation>Specialist in Anesthesiology</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract>Background: Hyponatremia, a frequent yet potentially life-threatening electrolyte &lt;br /&gt;imbalance, poses heightened risks in intensive care contexts. This investigation sought to &lt;br /&gt;explore contributory factors linked to hyponatremia following linezolid administration in &lt;br /&gt;critically ill (CI) individuals and to formulate a robust predictive framework. &lt;br /&gt;Methods: A retrospective evaluation was conducted on clinical records and follow-up data &lt;br /&gt;from 200 CI patients who received linezolid therapy. To isolate key determinants, logistic &lt;br /&gt;regression modeling was utilized, followed by validation using Receiver Operating &lt;br /&gt;Characteristic (ROC) curve analysis. A nomogram-based risk assessment tool was then &lt;br /&gt;constructed, with calibration tested via the Hosmer-Lemeshow goodness-of-fit approach. &lt;br /&gt;Findings: Adverse reactions were recorded in 23.5% of the cohort. Statistically significant &lt;br /&gt;disparities (P &lt; 0.05) emerged between CI and non-CI patients across several variables, &lt;br /&gt;including linezolid serum levels, therapy duration (DOM), baseline sodium values (BSS), &lt;br /&gt;estimated glomerular filtration rate (eGFR), white blood cell (WBC) count, total bilirubin &lt;br /&gt;(TBIL), albumin (ALB), and key biomarkers (NGAL, suPAR, Cystatin C), as well as concurrent &lt;br /&gt;spironolactone usage. The Z-score presented the highest diagnostic efficacy for &lt;br /&gt;hyponatremia, with a threshold of -3.24. The model demonstrated an 85.5% predictive &lt;br /&gt;accuracy, and the nomogram—based on multivariate regression and fit assessment—&lt;br /&gt; exhibited excellent alignment with actual outcomes. &lt;br /&gt;Interpretation: Independent predictors of hyponatremia included DOM, drug &lt;br /&gt;concentration, BSS, eGFR, and TBIL. Incorporation of novel biomarker profiles modestly &lt;br /&gt;improved model precision, suggesting added value in patient risk stratification. The &lt;br /&gt;developed tool offers promise for early detection and intervention in vulnerable ICU &lt;br /&gt;populations. </Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Intensive care patients</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Electrolyte Imbalance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Linezolid</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prognostic factors</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nomogram model</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Clinical utility</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_229209_1f839eaf42afd55417c65ba26e4d9404.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>06</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Muscle Morphology and Its Role in Chronic Neck Pain: A Review Article</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>11</LastPage>
			<ELocationID EIdType="pii">216784</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.509466.1007</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Sadegh</FirstName>
					<LastName>Shirdel</LastName>
<Affiliation>Orthopedic Surgeon, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hosein</FirstName>
					<LastName>Meskar</LastName>
<Affiliation>Associate Professor of Anesthesiology and Pain, Pain Specialist, Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Shahrezaee</LastName>
<Affiliation>Trauma and Surgery Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Chamanara</LastName>
<Affiliation>Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amin</FirstName>
					<LastName>Ghanbarpour Juybari</LastName>
<Affiliation>Anesthesiologist, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Chronic neck pain (CNP) is a common and debilitating condition that significantly impacts quality of life, productivity, and overall well-being. Muscle morphology, particularly in the deep cervical muscles, plays a critical role in the onset, development, and persistence of chronic neck pain. This review investigates the relationship between muscle changes, including atrophy, fat infiltration, and alterations in muscle fiber composition, and their contribution to cervical instability, pain, and functional limitations.&lt;br /&gt;&lt;br /&gt;Methods: The review examines existing literature on muscle morphology in CNP, focusing on the role of deep cervical muscles in the pathophysiology of neck pain. It also highlights how factors such as disuse, changes in neural activation, and chronic inflammation exacerbate these muscle alterations. The role of advanced imaging techniques, such as MRI, in identifying these changes is also discussed.&lt;br /&gt;&lt;br /&gt;Results: Alterations in muscle morphology, including atrophy and fat infiltration, contribute to weakness and reduced spinal stability, which are key factors in the development and persistence of chronic neck pain. Neural activation changes and chronic inflammation further exacerbate muscle degeneration. Advanced imaging techniques, particularly MRI, play a crucial role in assessing these morphological changes and enabling personalized treatment strategies.&lt;br /&gt;&lt;br /&gt;Conclusion: Muscle degeneration, including atrophy and fat infiltration in the cervical spine, is a significant factor in chronic neck pain. Effective management requires a comprehensive approach, including rehabilitation programs focused on muscle strengthening, postural correction, and ergonomic adjustments. Fat infiltration in cervical muscles is a significant marker of structural and functional impairment in cervical spine disorders. Further research is needed to explore the mechanisms behind muscle changes in CNP and to develop more targeted and effective interventions.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">chronic neck pain</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">muscle morphology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">fat infiltration</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">cervical instability</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MRI</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Rehabilitation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_216784_f5a447f2bee9132d96641a9c49f6010e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>06</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparing Different Treatment Options for Plantar Fasciitis, A Review Article</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>7</LastPage>
			<ELocationID EIdType="pii">216785</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.509508.1008</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Shahrezaee</LastName>
<Affiliation>Trauma and Surgery Research Center, Aja University of Medical Sciences, Tehran, Iran
Biomaterial and Medicinal Chemistry Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Sadegh</FirstName>
					<LastName>Shirdel</LastName>
<Affiliation>Orthopedic Surgeon, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Chamanara</LastName>
<Affiliation>Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hosein</FirstName>
					<LastName>Meskar</LastName>
<Affiliation>Associate Professor of Anesthesiology and Pain, Pain Specialist, Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Abolfazl</FirstName>
					<LastName>Firouzian</LastName>
<Affiliation>Associate Professor of Anesthesiology, Pain Management Department of Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Majid</FirstName>
					<LastName>Sadeghi</LastName>
<Affiliation>Burn Care Nurse, Zarreh Hospital, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Plantar fasciitis is a prevalent condition characterized by chronic heel pain, primarily caused by inflammation of the plantar fascia. The condition significantly impairs daily activities and quality of life, presenting a challenge for healthcare providers. Numerous treatment modalities, ranging from conservative measures to invasive interventions, have been explored to manage the symptoms and promote healing. However, the effectiveness of these treatments, especially when combined, requires further evaluation.&lt;br /&gt;&lt;br /&gt;Methods: This review extracted data from existing studies comparing the effectiveness of corticosteroid injections (CSI) alone versus their combination with needling techniques (such as dry needling and percutaneous needle electrolysis) for chronic plantar fasciitis. The literature was assessed through systematic reviews, randomized controlled trials, and clinical studies that evaluated pain relief, functional recovery, and long-term outcomes. Studies on adjunctive treatments like extracorporeal shockwave therapy (ESWT) were also considered to provide a broader comparison.&lt;br /&gt;&lt;br /&gt;Results: Corticosteroid injections provide significant short-term pain relief but are limited in their long-term efficacy, with potential complications like tissue atrophy. Dry needling and other needling therapies, when used in combination with CSI, have shown improved long-term outcomes in terms of pain reduction and functional recovery. ESWT consistently outperformed other treatments in long-term studies for both pain management and functional improvement. Combining treatments appears to yield enhanced results, although conclusive evidence on optimal treatment protocols remains insufficient.&lt;br /&gt;&lt;br /&gt;Conclusion: Chronic plantar fasciitis requires a multi-faceted treatment approach. While corticosteroid injections remain a common short-term solution, combining them with needling techniques may offer superior long-term benefits. Extracorporeal shockwave therapy also shows promise for sustained relief. Further research is needed to establish optimal treatment protocols and to better understand the combined effects of these interventions. An individualized treatment strategy that addresses both symptoms and underlying causes is essential for improving patient outcomes.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Plantar fasciitis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">corticosteroid injections</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Dry needling</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pain relief</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">functional recovery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">shockwave therapy</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_216785_b752d4d4a50659f687816ecc6dac5c89.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Post-Stroke Dysphagia: Clinical Screening with GUSS and Its Role in , Tailored Nutritional Therapy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>10</LastPage>
			<ELocationID EIdType="pii">229210</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.229210</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Saaedeh</FirstName>
					<LastName>Chalaki</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hossein</FirstName>
					<LastName>Montazer</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mirsaeed</FirstName>
					<LastName>Ramazani</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract> Background: This investigation explored the clinical utility of the Gugging Swallowing &lt;br /&gt;Screen (GUSS) in identifying swallowing dysfunction following stroke and examined its &lt;br /&gt;application in designing individualized nutritional interventions. The study also assessed a &lt;br /&gt;set of physiological markers—brain-derived neurotrophic factor (BDNF), salivary cortisol, &lt;br /&gt;leptin, and growth differentiation factor-15 (GDF-15)—to determine their relationship with &lt;br /&gt;dysphagia severity, neural recovery, and clinical prognosis. &lt;br /&gt;Methods: A cohort of 174 individuals recovering from stroke underwent swallowing &lt;br /&gt;assessments using both the GUSS protocol and the traditional water swallow test (WST). &lt;br /&gt;Participants diagnosed with swallowing impairments were randomized into a control group &lt;br /&gt;(CG), which received standard medical care, and an observation group (OG), which received &lt;br /&gt;additional GUSS-guided stratified feeding regimens. Comparative analyses focused on &lt;br /&gt;changes in swallowing ability, emotional well-being, serum and salivary biomarker profiles, &lt;br /&gt;and occurrence of medical complications. &lt;br /&gt;Findings: GUSS outperformed WST in sensitivity and responsiveness (P &lt; 0.05), as shown &lt;br /&gt;by significantly higher effect size (ES) and standardized response mean (SRM). Patients in &lt;br /&gt;the OG exhibited notably greater improvement in deglutition function and fewer adverse &lt;br /&gt;outcomes than those in the CG (P &lt; 0.05). Post-treatment nutritional markers—albumin &lt;br /&gt;(Alb), prealbumin (PA), and transferrin (TNF)—were also more favorable in the OG. BDNF &lt;br /&gt;and leptin levels showed strong alignment with dysphagia grading, while elevated salivary &lt;br /&gt;cortisol was associated with stress-related swallowing issues. GDF-15 levels correlated &lt;br /&gt;significantly with dysphagia-related complications. Moreover, quality of life indicators—&lt;br /&gt; including mental, physical, and social dimensions—were significantly enhanced in the OG (P &lt;br /&gt;&lt; 0.05). &lt;br /&gt;Conclusion: GUSS proves to be a robust tool for early detection of post-stroke swallowing &lt;br /&gt;disorders and offers added clinical value when used to guide dietary intervention. The &lt;br /&gt;inclusion of stress, neuroplasticity, and inflammatory biomarkers—particularly salivary &lt;br /&gt;cortisol and GDF-15—adds depth to severity assessment and supports the development of &lt;br /&gt;personalized rehabilitation pathways.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Post</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">stroke dysphagia GUSS Individualized nutrition Biomarker profiling Neurorehabilitation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_229210_2912e8ed2610efd39744cf62fce80a9b.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>09</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Unraveling a Complex Case: A Multidisciplinary Exploration of Alveolar Hemorrhage, Jaundice, and Respiratory Distress in the Context of Leptospirosis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">228847</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.507495.1005</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Shayan</FirstName>
					<LastName>Sabeti Billandi</LastName>
<Affiliation>Medical student, Mazandaran University of Science, Faculty of Medicine, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-9373-6065</Identifier>

</Author>
<Author>
					<FirstName>Masoud</FirstName>
					<LastName>Maboudi</LastName>
<Affiliation>Assistant Professor, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>
<Identifier Source="ORCID">0000-0002-5074-1224</Identifier>

</Author>
<Author>
					<FirstName>Amir Saleh</FirstName>
					<LastName>Abdellahi</LastName>
<Affiliation>Medical Student, Department of Medicine, Faculty of Medicine, Mazandaran University of Medical sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>02</Month>
					<Day>19</Day>
				</PubDate>
			</History>
		<Abstract>Leptospirosis is a globally distributed zoonotic infection, more prevalent in tropical and low-income regions due to high temperatures, humidity, rainfall, and poor socioeconomic conditions. Individuals in high-risk occupations, such as farmworkers, veterinarians, and slaughterhouse employees, are particularly vulnerable. Early symptoms include fever, headache, myalgia, and conjunctival inflammation. Prompt diagnosis via culture and agglutination tests, along with early antibiotic treatment, can reduce complications and speed recovery. Adhering to hygiene and workplace safety measures is crucial for infection prevention and control.&lt;br /&gt;&lt;br /&gt;This report presents the case of a 45-year-old male with fever, jaundice, and multiple systemic symptoms, with a history of chronic kidney disease and recent rice paddy exposure. He was admitted to Razi Hospital in Qaemshahr, where his condition rapidly deteriorated, requiring multidisciplinary intervention from nephrology, infectious disease, pulmonology, and psychiatry specialists. Initial findings revealed severe thrombocytopenia (platelet count: 8,000) and elevated creatinine levels (6 mg/dL), prompting treatment with dexamethasone, ceftriaxone, fluid therapy, and dialysis. However, his worsening respiratory distress and alveolar bleeding led to ICU admission.&lt;br /&gt;&lt;br /&gt;Leptospirosis was suspected based on occupational exposure and was confirmed by positive IgM antibodies in urine PCR. Despite intensive interventions—including dialysis, pleural fluid drainage, and Shaldon catheter placement—the patient developed progressive pulmonary complications and eventually succumbed.&lt;br /&gt;&lt;br /&gt;This case highlights the diagnostic and management challenges of leptospirosis in a patient with preexisting comorbidities. It underscores the importance of a multidisciplinary approach in recognizing and addressing the complexities of infectious diseases in critical care settings.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Leptospirosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Alveolar hemorrhage</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">CKD</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ESRD</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ICU delirium</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_228847_6ac7cb7d2913d4e39373cc873360c576.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Radiation Dose-Response Relationship in Patients with Stage III Non-Small Cell Lung Cancer</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234363</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560131.1023</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sarwar Nawzad</FirstName>
					<LastName>Jafar</LastName>
<Affiliation>College of Education, Salahaddin University-Erbil, Iraq1</Affiliation>
<Identifier Source="ORCID">0000-0002-9990-1065</Identifier>

</Author>
<Author>
					<FirstName>Sabah Ali</FirstName>
					<LastName>Muhammed</LastName>
<Affiliation>Department of Medical Laboratory Assistant, Sava Technical and Vocational Institute, Iraq</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Background: The optimal radiation dose for stage III non-small cell lung cancer (NSCLC) remains unclear. This study aimed to investigate the radiation dose-response relationship in patients with stage III NSCLC treated with definitive radiation therapy.&lt;br /&gt;&lt;br /&gt;
Methods: This retrospective cohort study analyzed 376 patients with stage III NSCLC treated with definitive radiation therapy between 2010 and 2019. The study population had a median age of 68 years, with 64.9% being male and 89.4% having a performance status of ECOG 0-1. The median radiation dose was 66 Gy, with 74.5% of patients receiving conventional fractionation and 25.5% receiving hypofractionated radiation.&lt;br /&gt;&lt;br /&gt;
Results: The median overall survival (OS) was 24.5 months, with a 95% confidence interval (CI) of 13.1-32.9 months. For every 1 Gy increase in radiation dose, the hazard of death decreases by 6% (HR = 0.94, p &lt; 0.001). Older age is associated with a higher hazard of death (HR = 1.02, p = 0.002). Poorer performance status (ECOG 2-3) is associated with a higher hazard of death compared to good performance status (ECOG 0-1) (HR = 1.63, p = 0.009). Histology other than adenocarcinoma is associated with a higher hazard of death (HR = 1.55, p = 0.02).  The results of the PCA suggest that the 15 dosimetric variables can be reduced to 5 components that explain 88.4% of the variance in the data suggesting that higher doses to smaller tumor volumes may be associated with better treatment outcomes.&lt;br /&gt;&lt;br /&gt;
Conclusion: Higher radiation doses may be associated with improved OS, but in patients with smaller tumor size. Further studies are needed to confirm these findings and to determine the optimal radiation dose for this patient population.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Lung cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radiation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Dose-response</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234363_befa462583ac10a2de33be4ab5d7b211.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>10</Month>
					<Day>24</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Awareness, Attitude, and Performance of Operating Room Technologists Toward the Prevention of Pressure Ulcers in Patients Candidate for Surgery</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">232803</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.550143.1019</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Fereshteh</FirstName>
					<LastName>Sargolzaei</LastName>
<Affiliation>Instructor of Operating Room, Department of Operating Room Technology, Iranshahr University of Medical Sciences, Iranshahr, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Moslem</FirstName>
					<LastName>Birami</LastName>
<Affiliation>Instructor, Department of Operating Room, Khoy University of Medical Sciences, Khoy, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Afsaneh</FirstName>
					<LastName>Poodineh</LastName>
<Affiliation>Instructor, Department of Operating Room, School of Nursing and Midwifery, Bam University of Medical Sciences, Bam, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Jebraeil</FirstName>
					<LastName>Farzi</LastName>
<Affiliation>Assistant Professor, Department of Health Information Technology, School of Allied Medical Sciences, Zabol University of Medical Sciences, Zabol, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Najme</FirstName>
					<LastName>Ghiami Keshtgar</LastName>
<Affiliation>Instructor of Operating Room, Department of Operating Room Technology, School of Nursing and Midwifery, Community Nursing Research Center, Zahedan University of Medical Sciences, Zahedan, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Background and purpose: Pressure ulcers are common postoperative complications that increase morbidity, mortality, and healthcare costs. Operating room (OR) technologists play a critical role in preventing pressure ulcers through proper skin care. This study aimed to assess the knowledge, attitude, and performance of OR technologists regarding skin care and pressure ulcer prevention.&lt;br&gt;Materials and methods: This descriptive-analytical, cross-sectional study was conducted from September to December 2022. Using a census sampling method, we included 58 operating room technologists from the educational hospitals affiliated with Zahedan University of Medical Sciences. Data were collected using a researcher-made questionnaire assessing knowledge, attitude, and performance. The data were analyzed using SPSS version 21, employing descriptive statistics, independent t-tests, and ANOVA.&lt;br&gt;Results: The mean and standard deviation of knowledge, attitude, and performance scores were 38.00 ± 15.00, 33.00 ± 6.00, and 23.00 ± 4.00, respectively. Most operating room technologists demonstrated a positive attitude, relatively good knowledge, and average performance toward pressure ulcer prevention. There was a significant relationship between knowledge scores and the age of operating room technologists (p &lt; 0.0001).&lt;br&gt;Conclusion: The results of this study highlight the importance of knowledge, attitude, and performance among operating room professionals in reducing the risk of pressure ulcers in patients surgical candidates.. It can be suggested that in the field of skincare and prevention of pressure ulcers in the operating room, basic pressure ulcer training should be included at the beginning of the operating room courses and in the in-service training of operating room experts.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Pressure Ulcers</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Operating Room Technologists</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Knowledge</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Attitude</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">performance</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Patient skincare</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Prevention strategies</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_232803_2b3c99b52994059529cd64cab7a7303c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Stereotactic Body Radiation Therapy for Oligometastatic Lung Cancer: A Retrospective Study of Predictors of Adverse Events</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234359</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560122.1021</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ruaa Emad</FirstName>
					<LastName>Al-Khalidi</LastName>
<Affiliation>MSc.in medical physics , Hawler Medical University, College of Medicine, Department of Pharmacology and Medical Physics and Clinical Biochemistry, Erbil, Iraq.</Affiliation>
<Identifier Source="ORCID">0009-0009-4742-3952</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Background: Oligometastatic lung cancer is a clinical entity characterized by a limited number of metastases, and stereotactic body radiation therapy (SBRT) has emerged as a promising treatment option for this condition. However, the relationship between SBRT dose and adverse events in this population is not well understood.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Objectives: To evaluate the treatment outcomes and adverse events associated with SBRT in patients with oligometastatic lung cancer, and to investigate the relationship between radiation dose and adverse events.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Methods: This retrospective chart review included 81 patients with oligometastatic lung cancer who underwent SBRT at a single institution between 2015 and 2023. Patients received SBRT with a dose of 30-60 Gy in 3-10 fractions. Data on patient demographics, tumor characteristics, treatment details, and adverse events were collected and analyzed.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Results: The study found that 37% of patients experienced adverse events of grade ≥2, with fatigue, dermatitis, and cough being the most common. Multivariate analysis revealed that higher radiation dose was significantly associated with increased risk of adverse events (OR 1.05, 95% CI 1.01-1.09, p=0.01). Other factors, including age, sex, ECOG performance status, and previous chemotherapy, were not significantly associated with adverse events.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Conclusion: This study demonstrates that SBRT higher radiation doses are associated with increased risk of adverse events with no other risk factor predicting adverse event occurrence. These findings highlight the importance of careful treatment planning and dose optimization to minimize toxicity while maintaining treatment efficacy.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Stereotactic Body Radiation Therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Oligometastatic Lung Cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Adverse events</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radiation dose</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">treatment outcomes</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234359_5b7ef5acf30517ec548b3ae689c4ce85.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Cost-Effectiveness Analysis of Radiation Therapy versus Surgery for Early-Stage Laryngeal Squamous Cell Carcinoma (T1-T2)</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234361</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560126.1022</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sara Sarood</FirstName>
					<LastName>Alnaqishbandi</LastName>
<Affiliation>Koya ,Shaheed Doctor Majeed Radiology Center, Iraq</Affiliation>

</Author>
<Author>
					<FirstName>Sabah Ali</FirstName>
					<LastName>Mohammed</LastName>
<Affiliation>Department of Medical Laboratory Assistant, Sava Technical and Vocational Institute, Iraq</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Background: Early-stage laryngeal squamous cell carcinoma (T1-T2) can be treated with either radiation therapy or surgery, but the cost-effectiveness of these treatments is unclear.&lt;br /&gt;&lt;br /&gt;
Methods: This study is a cost-effectiveness analysis comparing radiation therapy and surgery as treatments for early-stage laryngeal squamous cell carcinoma (T1-T2) at a university hospital&#039;s tertiary care center. A consecutive sampling method was used to select 86 patients (43 per group) diagnosed with early-stage laryngeal squamous cell carcinoma (T1-T2) between January 2018 and December 2020. Demographic, clinical, and cost data were collected, and quality of life data were collected using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30).&lt;br /&gt;&lt;br /&gt;
Results: The mean total cost for patients treated with radiation therapy was ¥123,419, which was significantly lower than the mean total cost for patients treated with surgery (¥153,219, p=0.012). The mean QALYs for patients treated with radiation therapy was 4.21 (± 1.23), which was slightly higher than the mean QALYs for patients treated with surgery (3.92 ± 1.35), but the difference was not statistically significant (p=0.142). The incremental cost-effectiveness ratio (ICER) was ¥24,011 per QALY gained, indicating that radiation therapy was associated with a lower cost per QALY gained compared to surgery. At a willingness-to-pay (WTP) threshold of ¥50,000 per QALY, the probability that radiation therapy is cost-effective is 72.1%.&lt;br /&gt;&lt;br /&gt;
Conclusion: Radiation therapy is a cost-effective treatment option for early-stage laryngeal squamous cell carcinoma (T1-T2) compared to surgery, with a lower ICER and a higher probability of cost-effectiveness at various WTP thresholds. These findings can inform treatment decisions and resource allocation in the management of early-stage laryngeal squamous cell carcinoma.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Laryngeal Neoplasms</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Carcinoma, Squamous Cell</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radiation oncology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Surgery</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cost-benefit analysis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Quality-Adjusted Life Years</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234361_598832d34d21676473bffb5e17533133.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>03</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Osteoporosis: Pharmacological Treatments, Pain Management, and Their Implications for Clinical Practice</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>8</LastPage>
			<ELocationID EIdType="pii">217483</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.509428.1006</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mostafa</FirstName>
					<LastName>Shahrezaee</LastName>
<Affiliation>Trauma and Surgery Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Chamanara</LastName>
<Affiliation>Toxicology Research Center, Aja University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Sadegh</FirstName>
					<LastName>Shirdel</LastName>
<Affiliation>Orthopedic Surgeon, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hosein</FirstName>
					<LastName>Meskar</LastName>
<Affiliation>Associate Professor of Anesthesiology and Pain, Pain Specialist, Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sadegh</FirstName>
					<LastName>Taheri</LastName>
<Affiliation>Orthopedic Surgeon, Orthopedic Research Center, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amin</FirstName>
					<LastName>Ghanbarpour Juybari</LastName>
<Affiliation>Anesthesiologist, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Goli</FirstName>
					<LastName>Aezzi</LastName>
<Affiliation>Fellowship Pain Medicine, Department of Anesthesiology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>02</Month>
					<Day>28</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: Osteoporosis is a widespread bone disease characterized by low bone mineral density (BMD), structural bone deterioration, and an increased risk of fractures. It primarily affects postmenopausal women and the elderly, representing a significant global health burden. The management of osteoporosis involves pharmacological treatments aimed at preventing fractures, alleviating symptoms, and improving overall quality of life.&lt;br /&gt;Methods: This review analyzes the pharmacology of current osteoporosis treatments, including bisphosphonates, selective estrogen receptor modulators (SERMs), monoclonal antibodies, and newer agents such as sclerostin inhibitors. It also examines pain management strategies, particularly those targeting fracture-related pain, and explores the intersection between bone therapies and analgesia.&lt;br /&gt;Results: The current pharmacological treatments for osteoporosis have shown significant efficacy in reducing fracture risk. However, managing pain in osteoporosis, particularly post-fracture pain, remains a complex challenge. This review highlights the need for a multidimensional approach that integrates both bone-targeted therapies and effective pain management strategies.&lt;br /&gt;Conclusion: While osteoporosis therapies have greatly reduced fracture risk, pain management in osteoporosis patients remains an area requiring further research. This review synthesizes current literature on osteoporosis treatments and pain management, offering insights into best practices and identifying future research directions to improve patient outcomes.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Osteoporosis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Fracture Risk</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bisphosphonates</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">SERMs</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Pain management</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sclerostin Inhibitors</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_217483_d7c59750fa6cfd29fb2c7b9e876bf776.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Comparative Analysis of Radiation Therapy Outcomes in Breast Cancer Patients with and without Prior Chemotherapy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234364</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560136.1024</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Sarhang Hasan</FirstName>
					<LastName>Azeez</LastName>
<Affiliation>College of Education, Salahaddin University-Erbil, Iraq</Affiliation>
<Identifier Source="ORCID">0000-0002-1327-0136</Identifier>

</Author>
<Author>
					<FirstName>Ismael Bilal Ismael</FirstName>
					<LastName>Altutunchi</LastName>
<Affiliation>College of Nursing, Hawler Medical University, Iraq</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Background: Neoadjuvant chemotherapy is a common treatment approach for breast cancer, but its impact on disease-free survival, quality of life, and recurrence rates is not well understood.&lt;br /&gt;&lt;br /&gt;
Objectives: To evaluate the association between neoadjuvant chemotherapy and disease-free survival, quality of life, and recurrence rates in patients with breast cancer.&lt;br /&gt;&lt;br /&gt;
Methods: This retrospective cohort study included 350 patients with breast cancer who underwent surgery at a university clinic between 2015 and 2022. Patients were divided into two groups: those who received neoadjuvant chemotherapy (n=105) and those who did not (n=245). Demographic, tumor, and treatment characteristics were compared between groups. Disease-free survival, quality of life, and recurrence rates were analyzed using Cox proportional hazards models, multivariate analysis of variance, and logistic regression models. 1 year follow ups were made. &lt;br /&gt;&lt;br /&gt;
Results: Patients who received neoadjuvant chemotherapy had a significant reduction in the risk of disease recurrence (HR=0.65, p=0.02) and local recurrence (OR=0.42, p=0.01). However, they had lower physical and social functioning scores compared to those who did not receive neoadjuvant chemotherapy (p=0.04 and p=0.02, respectively). Neoadjuvant chemotherapy was also associated with a higher survival rate at 12 months (92.5% vs. 85.1%, p=0.03).&lt;br /&gt;&lt;br /&gt;
Conclusions: Neoadjuvant chemotherapy is associated with improved disease-free survival and reduced local recurrence rates in patients with breast cancer. However, it may have a negative impact on quality of life, particularly physical and social functioning. These findings have implications for the management of breast cancer and highlight the need for further research on the optimal use of neoadjuvant chemotherapy.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Neoadjuvant chemotherapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">disease-free survival</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Quality of Life</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">recurrence rates</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234364_18de07398fde0ebb0e145943b8acf9cf.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Integrated Use of Cardiac and Vascular Biomarkers ,in Forecasting Major Cardiovascular Outcomes</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>10</LastPage>
			<ELocationID EIdType="pii">229211</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.229211</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Saaedeh</FirstName>
					<LastName>Chalaki</LastName>
<Affiliation>Emergency Medicine Specialist</Affiliation>

</Author>
<Author>
					<FirstName>Iraj</FirstName>
					<LastName>Goli Khatir</LastName>
<Affiliation>Emergency Medicine Specialist</Affiliation>
<Identifier Source="ORCID">0000-0002-4708-7874</Identifier>

</Author>
<Author>
					<FirstName>Banafsheh</FirstName>
					<LastName>Noori GharnSaraei</LastName>
<Affiliation>Cardiology Specialist</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract>This forward-looking clinical investigation explored the prognostic utility of four distinct &lt;br /&gt;biomarkers—high-sensitivity cardiac troponin T (hs-cTnT), N-terminal pro b-type &lt;br /&gt;natriuretic peptide (NT-proBNP), Copeptin, and Mid-regional pro-Adrenomedullin (MR&lt;br /&gt;proADM)—in forecasting significant cardiovascular complications among 120 individuals &lt;br /&gt;presenting with symptoms suggestive of acute coronary syndrome (ACS) in an emergency &lt;br /&gt;care setting. Across a 12-month observation window, occurrences of major adverse &lt;br /&gt;cardiovascular events (MACE)—encompassing myocardial infarction, stroke, and &lt;br /&gt;cardiovascular mortality—were systematically tracked and correlated with both initial and &lt;br /&gt;serial biomarker measurements. &lt;br /&gt;Multivariate analysis using Cox proportional hazards modeling, adjusted for demographic &lt;br /&gt;and behavioral risk factors such as age, sex, and smoking, revealed a robust association &lt;br /&gt;between elevated biomarker levels and MACE incidence. Diagnostic accuracy for each &lt;br /&gt;marker—individually and collectively—was assessed through ROC curve analysis, &lt;br /&gt;demonstrating favorable area under the curve (AUC) values indicative of strong predictive &lt;br /&gt;performance. Survival outcomes stratified by median biomarker thresholds were estimated &lt;br /&gt;using Kaplan-Meier methodology, showing pronounced differences in MACE-free survival &lt;br /&gt;between high- and low-risk groups. &lt;br /&gt;The findings affirm the clinical value of hs-cTnT, NT-proBNP, Copeptin, and MR-proADM in &lt;br /&gt;early cardiovascular risk stratification. Moreover, the integrative use of these markers was &lt;br /&gt;shown to outperform any single biomarker alone, emphasizing their combined role in &lt;br /&gt;refining diagnostic precision and guiding therapeutic decisions. These results support &lt;br /&gt;incorporating such biomarker panels into routine evaluation protocols for patients &lt;br /&gt;undergoing assessment for suspected ACS.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Cardiac troponin T NT</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">proBNP Copeptin MR</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">proADM Acute coronary presentations Cardiovascular event prediction Multimarker risk assessment</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_229211_fcdc5c4452ef837eb2e350b061f47b26.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Radiation Dose and Volume Effects on Cognitive Function in Patients with Glioblastoma Multiforme (GBM) Treated with Radiation Therapy and Temozolomide</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234365</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560137.1025</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ismael Bilal Ismael</FirstName>
					<LastName>Altutunchi</LastName>
<Affiliation>College of Nursing, Hawler Medical University, Iraq</Affiliation>

</Author>
<Author>
					<FirstName>Sarhang Hasan</FirstName>
					<LastName>Azeez</LastName>
<Affiliation>Department of Pharmacy Assistant, Sava technical and Vocational Institute, Iraq</Affiliation>
<Identifier Source="ORCID">0000-0002-1327-0136</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Background: Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with a poor prognosis. Radiation therapy (RT) and temozolomide (TMZ) are standard treatments, but their impact on cognitive function is not well understood.&lt;br /&gt;&lt;br /&gt;
Objective: To investigate the effects of radiation dose and TMZ dose on cognitive function in patients with GBM treated with RT and TMZ.&lt;br /&gt;&lt;br /&gt;
Methods: This retrospective study included 162 patients with GBM treated with RT and TMZ between 2018 and 2023. Cognitive function was assessed using a comprehensive battery of neuropsychological tests, and MRI-based measures of cognitive function were obtained. Patients were categorized into three groups based on radiation dose received: low dose (&lt; 50 Gy), moderate dose (50-60 Gy), and high dose (&gt; 60 Gy). Follow ups were made up to 8 to 12 months after chemoradiotherapy. &lt;br /&gt;&lt;br /&gt;
Results: Patients in the high dose group performed significantly worse on executive function and memory tests, and had reduced white matter integrity and increased white matter hyperintensity volume compared to the low dose group. Higher TMZ doses were associated with poorer cognitive outcomes in executive function, memory, and reduced hippocampal volume. Linear regression analysis showed that higher radiation doses were associated with poorer cognitive outcomes in memory, and higher TMZ doses were associated with poorer cognitive outcomes in executive function, memory, and reduced hippocampal volume.&lt;br /&gt;&lt;br /&gt;
Conclusion: This study suggests that higher radiation doses and TMZ doses are associated with poorer cognitive outcomes in patients with GBM. These findings have important implications for the management of GBM, highlighting the need to minimize radiation dose and TMZ dose to prevent cognitive decline. Future studies are needed to confirm these findings and to explore strategies to mitigate the cognitive effects of RT and TMZ in patients with GBM.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Glioblastoma Multiforme</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Radiation therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Temozolomide</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cognitive Function</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Neuropsychological Tests</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MRI-Based Measures</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234365_39549bed2be7bcbb6675369aac5aff3b.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>16</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Targeted Antimicrobial Therapy in Urosepsis: A Review of Clinical Evidence and Inflammatory Marker Dynamics</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234366</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.557936.1020</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Behkam</FirstName>
					<LastName>Rezaiemehr</LastName>
<Affiliation>Assistant Professor, Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Laripour</LastName>
<Affiliation>Infectious Diseases Research Center, AJA University of Medical Sciences, Tehran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Alikhani</LastName>
<Affiliation>Associate Professor, Infectious Diseases Department and Antimicrobial Resistance Research Center and Transmissible Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mohsen</FirstName>
					<LastName>Yadollahi</LastName>
<Affiliation>PhD Student in Food Hygiene, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehdi</FirstName>
					<LastName>Younesi Rostami</LastName>
<Affiliation>Assistant Professor, Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Deylami</LastName>
<Affiliation>Assistant Professor, Department of Urology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>06</Day>
				</PubDate>
			</History>
		<Abstract>Urosepsis is a severe, life-threatening condition caused by the rapid dissemination of urinary-tract pathogens into the bloodstream and an uncontrolled host inflammatory response. The emergence of multidrug-resistant organisms and the variability of immune activation in critically ill patients have made its management increasingly complex. Targeted antimicrobial therapy (TAT)—defined as the selection of antibiotics based on microbiological identification and susceptibility testing—embodies the principles of precision medicine, aiming to optimize treatment effectiveness while minimizing broad-spectrum exposure and the spread of resistance.&lt;br /&gt;&lt;br /&gt;
This review synthesizes the current evidence regarding the role of TAT in urosepsis, highlighting its effects on systemic inflammation, organ function, and clinical outcomes. Special attention is given to novel biomarkers such as Presepsin, neutrophil CD64 index, and Copeptin, examined alongside classical inflammatory mediators including tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and C-reactive protein (CRP). Collectively, these markers provide valuable insights into the interplay between pathogen control and immune modulation. The review also discusses diagnostic and operational barriers to implementing TAT, the variability of antimicrobial stewardship across institutions, and future research directions aimed at integrating biomarker-guided targeted therapy into individualized sepsis management.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Urosepsis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Targeted antimicrobial therapy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">precision medicine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">inflammatory biomarkers</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Presepsin</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Neutrophil CD64</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Copeptin</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234366_53db44f4444846e55228ebad54bd52f7.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>17</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Effect of Inhaled Salbutamol on Pain Severity in Patients Presenting with Acute Renal Colic: A Double-Blind Randomized Clinical Trial</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234477</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.531758.1016</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Seyed Mohammad</FirstName>
					<LastName>Hosseininejad</LastName>
<Affiliation>Assistant Professor of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Iraj</FirstName>
					<LastName>Goli Khatir</LastName>
<Affiliation>Assistant Professor of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hoseinali</FirstName>
					<LastName>Khodadadi</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>06</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Background: Renal colic is a common and severely painful emergency condition often caused by ureteral stones. Rapid pain management is critical. This study evaluates the efficacy of inhaled salbutamol, a β2-agonist with smooth muscle relaxant properties, as an adjunct therapy in reducing pain severity in patients with acute renal colic.&lt;br /&gt;&lt;br /&gt;
Methods: In this double-blind randomized controlled trial, 204 patients with moderate renal colic pain (based on the Visual Analog Scale, VAS) referred to the emergency department of Imam Khomeini Hospital in Sari, Iran, were randomly assigned to two groups. The intervention group received 30 mg intravenous ketorolac and inhaled salbutamol (5 puffs), while the control group received ketorolac and a placebo inhalation. Pain intensity, vital signs, and symptoms such as nausea and vomiting were recorded at baseline and at intervals of 10, 20, 30, 45, 60, and 120 minutes after treatment.&lt;br /&gt;&lt;br /&gt;
Results: Pain intensity significantly decreased over time in both groups (p</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Renal colic</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Salbutamol</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Acute pain</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Emergency medicine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Clinical trial</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">VAS</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234477_18a6df65c925ed786618e6b5c1fa7551.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>17</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Investigation of Factors Influencing the Effectiveness of Levetiracetam, Lamotrigine, and Lacosamide in Brain Tumor-Related Epilepsy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234478</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.543933.1018</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Nasim</FirstName>
					<LastName>Tabrizi</LastName>
<Affiliation>Associate Professor of Neurology, Fellowship of Epilepsy, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mehran</FirstName>
					<LastName>Frouzanian</LastName>
<Affiliation>Student Research Center, Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Sajjad</FirstName>
					<LastName>Shafiee</LastName>
<Affiliation>Associate Professor of Neurological Surgery, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>08</Month>
					<Day>29</Day>
				</PubDate>
			</History>
		<Abstract>Brain tumor-related epilepsy (BTRE) is a prevalent complication, affecting 25-60% of patients with primary or metastatic brain tumors, significantly impacting quality of life and complicating oncologic management. This narrative review examines factors influencing the effectiveness of levetiracetam (LEV), lamotrigine (LTG), and lacosamide (LCS) in BTRE. By analyzing epidemiological data, pathophysiological mechanisms, pharmacological profiles, and clinical evidence, we study how tumor characteristics (type, location, molecular profile), patient-specific factors (age, comorbidities), drug interactions, and pharmacodynamic properties modulate seizure control. LEV is often the first-line choice due to its favorable tolerability and minimal drug interactions, achieving seizure freedom in 65-80% of patients in some studies. LTG and LCS, effective as monotherapy or add-on therapies with response rates of 50-70%, vary in efficacy based on tumor histology and peritumoral microenvironment. Challenges include drug resistance linked to glutamate excitotoxicity, sodium channel dysregulation, and tumor-driven molecular changes. Research gaps, such as long-term comparative trials and personalized dosing strategies, highlight the need for further investigation. Optimizing AED selection in BTRE requires a multidisciplinary approach to balance seizure control, antitumor therapy efficacy, and adverse effect minimization, emphasizing personalized medicine.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Brain neoplasms</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Epilepsy</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">seizures</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Anticonvulsants</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Levetiracetam</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">lamotrigine</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Lacosamide</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234478_b2d65815b52d85fcd2325006b1a96028.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>17</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Epidemiology of Spinal Fractures in Emergency Department Patients at Imam Khomeini Hospital, Sari</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234479</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.516445.1011</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Seyed Hossein</FirstName>
					<LastName>Montazer</LastName>
<Affiliation>MD, Emergency Medicine , Assistant professor, department of Emergency Medicine , Mazandaran university of medical sciences, sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Ahmad</FirstName>
					<LastName>Miri</LastName>
<Affiliation>, MD, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Amirsaleh</FirstName>
					<LastName>Abdollahi</LastName>
<Affiliation>Student Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>04</Month>
					<Day>12</Day>
				</PubDate>
			</History>
		<Abstract>Background: Spinal injuries are a significant cause of morbidity and mortality globally. Trauma-related spinal fractures contribute to the burden on healthcare systems and significantly affect the quality of life. Although substantial progress has been made in trauma care, spinal fractures, particularly those associated with spinal cord injuries (SCI), remain a leading cause of long-term disability. The epidemiology of spinal fractures varies regionally due to demographic, trauma mechanisms, and healthcare factors. In Iran, motor vehicle accidents and falls from heights are prominent causes of spinal injuries, but regional data on the epidemiology of these injuries, particularly from smaller cities, is scarce.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Materials and Methods: This retrospective cohort study was conducted at Imam Khomeini Hospital in Sari, Mazandaran province, Iran, reviewing the records of 288 patients with spinal fractures treated between March 2014 and March 2018. Data collected included demographic characteristics (age and gender), injury mechanisms, fracture locations, fracture types, presence of spinal cord injuries, and clinical outcomes. The analysis also included the association between injury mechanisms and fracture types using statistical tests.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Results: The study included 288 patients, with 75% being male and a mean age of 39.21 years. The most common mechanisms of injury were motor vehicle accidents (47.2%) and falls from height (35.4%). Cervical spine fractures were the most common, accounting for 49% of cases. Burst fractures were the most prevalent type of fracture (40.5%). Spinal cord injuries were present in 21.2% of the patients, with a higher incidence in those injured by vehicle accidents. The mortality rate was 3.1%, and 42.4% of patients underwent surgical intervention. The average hospital stay was 7.53 days.&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;
Conclusion: This study provides a comprehensive epidemiological profile of spinal fractures in a regional Iranian hospital. It highlights the high incidence of spinal fractures due to motor vehicle accidents and falls from height, with cervical spine fractures and burst fractures being the most common. The presence of spinal cord injury is significant and underscores the need for early diagnosis and effective treatment. . Further studies, particularly prospective ones, are needed to better understand the long-term outcomes of spinal injuries and SCI in Iran.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Epidemiology</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Spinal fractures</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Emergency Department</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Sari</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234479_96c316e08af78cb2e15beedb6bb3033c.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>19</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Distinct Heritable Architectures in Esophageal Cancer Revealed by Two Decades of Genome-Wide Association Studies</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234562</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560806.1027</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ruaa Emad</FirstName>
					<LastName>Al-Khalidi</LastName>
<Affiliation>MSc.in medical physics , Hawler Medical University, College of Medicine, Department of Pharmacology and Medical Physics and Clinical Biochemistry, Erbil- Iraq. Ruaa Emad Al-Khalidi 0009-0009-4742-3952</Affiliation>
<Identifier Source="ORCID">0009-0009-4742-3952</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>19</Day>
				</PubDate>
			</History>
		<Abstract>Objective To integrate the latest evidence regarding inherited genetic risk factors for esophageal cancer while emphasizing contrasting susceptibility profiles between esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC)/Barrett’s esophagus as this integration also allows assessment of how genome-wide association studies (GWAS) together with new trans-ancestry genomic methods have advanced the discovery of risk loci and their potential clinical application.  &lt;br /&gt;&lt;br /&gt;
Results More than 30 reliable risk loci are now recognized for ESCC mostly identified in East Asian populations with major signals located in PLCE1 alcohol/aldehyde metabolism genes ADH/ALDH2 (showing strong interaction with alcohol consumption) CHEK2 and HLA-region immune pathways whereas recent trans-ancestry studies have validated shared loci such as PLCE1 while uncovering novel African-enriched variants that highlight population-specific genetic architecture. By comparison EAC and Barrett’s esophagus present a separate genetic profile shaped largely by European-ancestry consortia featuring risk loci near BARX1 FOXP1 CRTC1 (involved in mucosal development) as well as CFTR MSRA BLK (linked to barrier function and oxidative stress) and although fewer loci have been found overall EAC exhibits considerable shared heritability with Barrett’s esophagus which supports the value of genetically guided surveillance.  &lt;br /&gt;&lt;br /&gt;
Conclusion ESCC and EAC display strikingly different inherited risk patterns that closely reflect their distinct environmental risk factors as this difference now permits the construction of polygenic risk scores that incorporate subtype-specific GWAS findings together with emerging rare-variant and functional genomic information thereby enabling personalized risk assessment and more targeted screening in high-risk families and populations.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Esophageal squamous cell carcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Esophageal Adenocarcinoma</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Barrett’s Esophagus</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Genetic susceptibility</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Germline</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Genome-Wide Association Study (GWAS)</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234562_5a9c9f47791d6da96d5f9fce1d2c073e.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>19</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Role of Exercise in Cardiac Rehabilitation for Coronary Heart Disease: A Systematic Review</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234586</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.560885.1028</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mohammed Ibrahim Mohialdeen</FirstName>
					<LastName>Gubari</LastName>
<Affiliation>Assistant professor, Clinical Science Branch, College of Medicine, University of Sulaimani, Kurdistan Region of Iraq.</Affiliation>
<Identifier Source="ORCID">0000-0002-2873-3981</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>19</Day>
				</PubDate>
			</History>
		<Abstract>Background: Physical inactivity is a key risk factor for coronary heart disease (CHD). This systematic review explores the role of exercise in cardiac rehabilitation for CHD patients, emphasizing the integration of nuclear stress tests and tumor imaging techniques to assess heart function.&lt;br /&gt;&lt;br /&gt;
Materials and Methods: A systematic review was conducted, analyzing randomized controlled trials (RCTs) indexed in the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and EMBASE. Studies were selected based on criteria related to exercise-based cardiac rehabilitation, including outcomes such as cardiovascular mortality, hospitalization, and quality of life. Imaging methods, such as nuclear stress tests and tumor imaging, were also considered. The quality of the studies was assessed using the Cochrane Risk of Bias tool.&lt;br /&gt;&lt;br /&gt;
Results: Five RCTs were included in the final analysis. The reviewed literature consistently reported that exercise-based cardiac rehabilitation led to reductions in cardiovascular mortality and hospital admissions, alongside notable improvements in patient quality of life. The inclusion of nuclear stress tests was found to improve diagnostic accuracy for identifying myocardial ischemia and assessing heart function during exercise. Tumor imaging techniques were successfully used to identify cardiac tumors and monitor post-surgical heart function.&lt;br /&gt;&lt;br /&gt;
Conclusion: This systematic review supports the integration of exercise as a core component of cardiac rehabilitation programs for CHD patients. The findings indicate significant benefits in reducing cardiovascular mortality and improving quality of life. The use of nuclear stress tests and tumor imaging techniques enhances the precision of rehabilitation strategies, offering a more personalized approach to care.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Coronary heart disease</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cardiac Rehabilitation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Exercise training</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cardiac Stress Test</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Cardiovascular Mortality</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Imaging Methodologies</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Nuclear Stress Tests</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234586_17416025c9a4e67dae4e7f40f68ac5a5.pdf</ArchiveCopySource>
</Article>

<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>21</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Role of Acupuncture in Obesity Management: A Review of Clinical Efficacy and Imaging Evidence on Fat Distribution</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage></FirstPage>
			<LastPage></LastPage>
			<ELocationID EIdType="pii">234642</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.561197.1030</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Ruaa Emad</FirstName>
					<LastName>Al-Khalidi</LastName>
<Affiliation>Msc.In Medical Physics , Hawler Medical University, College Of Medicine, Department Of Pharmacology And Medical Physics And Clinical Biochemistry, Erbil- Iraq</Affiliation>
<Identifier Source="ORCID">0009-0009-4742-3952</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>11</Month>
					<Day>21</Day>
				</PubDate>
			</History>
		<Abstract>Introduction: The global prevalence of obesity has spurred interest in alternative therapies beyond conventional diet, exercise, and pharmacotherapy. Acupuncture, a staple of Traditional Chinese Medicine, is one such intervention, though its efficacy and mechanisms of action, particularly on fat distribution, warrant further synthesis of existing evidence.&lt;br /&gt;&lt;br /&gt;
&lt;br /&gt;&lt;br /&gt;
Objective: This review aims to critically appraise and summarize the current literature on the efficacy and safety of acupuncture for weight loss, with a special focus on insights provided by MRI and CT scan imaging regarding its impact on visceral and subcutaneous fat distribution.&lt;br /&gt;&lt;br /&gt;
&lt;br /&gt;&lt;br /&gt;
Methods: A narrative review of scientific literature was conducted. Key databases, including PubMed, Google Scholar, and ISI Web of Science, were searched for relevant clinical trials, reviews, and meta-analyses published up to September 2024. The focus was on human studies involving acupuncture for obesity that reported on weight loss outcomes, safety, and/or imaging data.&lt;br /&gt;&lt;br /&gt;
&lt;br /&gt;&lt;br /&gt;
Findings: The body of literature suggests that acupuncture may contribute to reductions in body weight and BMI. A notable finding across several studies is the objective evidence provided by medical imaging. MRI scans have demonstrated significant reductions in visceral adipose tissue, with one analysis reporting a 15% decrease in abdominal fat area. Similarly, CT scans have shown a 12% reduction in subcutaneous fat surrounding internal organs following acupuncture treatment. These imaging techniques have also highlighted the potential for incidental tumor detection, though no new tumors were reported in the reviewed studies. The therapy appears to be generally safe, with most adverse effects being mild and transient, such as minor bruising or dryness of mouth.&lt;br /&gt;&lt;br /&gt;
&lt;br /&gt;&lt;br /&gt;
Conclusion: Current evidence, including objective data from medical imaging, suggests that acupuncture may be a beneficial and safe complementary approach for weight management, particularly through the modulation of fat distribution. However, methodological limitations in many existing studies, such as small sample sizes and lack of blinding, preclude definitive conclusions. More rigorous, large-scale, and long-term studies are recommended to confirm these findings and elucidate the underlying mechanisms.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Obesity</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">electroacupuncture</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">weight loss</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Fat Distribution</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Visceral fat</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">CT scan</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MRI</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_234642_9dde10f6b67e33120a7368e39dbf43f8.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
